Optimal Dose of Rituximab in Abo-Incompatible Kidney Transplantation in Patients with Low Anti-A/B Antibody Titers: A Single-Center Retrospective Cohort Study

M. Okada,S. Narumi, N. Goto, T. Hiramitsu, K. Futamura, Y. Hasegawa, T. Ichimori,A. Takeda,K. Uchida,T. Kobayashi, K. Nishizawa, Y. Watarai

Clinical transplantation（2023）

引用 0|浏览6

暂无评分

摘要

In ABOi kidney transplantation patients with low anti-A/B antibody titers, the desensitization protocol with a single dose of 100 mg rituximab was effective in preventing acute AMR without increasing the risk of other adverse events.

查看译文

关键词

ABO-incompatibility,desensitization,kidney transplantation,rituximab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要